Detalhe da pesquisa
1.
Tetrameric Acetyl-CoA Acetyltransferase 1 Is Important for Tumor Growth.
Mol Cell
; 64(5): 859-874, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27867011
2.
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
Cancer
; 129(15): 2308-2320, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078412
3.
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.
Blood
; 138(1): 11-22, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33827116
4.
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
; 137(6): 751-762, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929488
5.
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
Lancet
; 398(10299): 491-502, 2021 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097852
6.
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.
Blood
; 135(7): 463-471, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31841594
7.
Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth.
Mol Cell
; 55(4): 552-65, 2014 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25042803
8.
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS).
Cancer
; 127(23): 4421-4431, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424530
9.
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
N Engl J Med
; 378(25): 2386-2398, 2018 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860938
10.
Secondary Adult Acute Myeloid Leukemia: a Review of Our Evolving Understanding of a Complex Disease Process.
Curr Treat Options Oncol
; 16(8): 37, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26143266
11.
Final phase I substudy results of ivosidenib in patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome.
Blood Adv
; 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38640348
12.
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.
J Immunother Cancer
; 11(8)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648261
13.
Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase.
Br J Haematol
; 158(5): 608-14, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22758202
14.
Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations.
Clin Cancer Res
; 28(13): 2753-2761, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35046058
15.
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.
J Hematol Oncol
; 15(1): 170, 2022 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36494725
16.
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.
JCO Oncol Pract
; 17(4): e497-e505, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33125295
17.
Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia.
Blood Adv
; 4(6): 983-992, 2020 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32168378
18.
Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates.
Blood Adv
; 7(11): 2360-2363, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315007
19.
Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
Clin Lymphoma Myeloma Leuk
; 16(8): 466-471.e1, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27297665
20.
Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth.
Cancer Cell
; 27(2): 257-70, 2015 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25670081